Many drug prices are going up in ’23 – brace yourselves

Prices on some 350 drugs are headed up, says a new report from Reuters and FiercePharma. And many of those are big names.

“Already, list prices on big-selling products such as AbbVie’s Imbruvica, AstraZeneca’s Tagrisso, Gilead Sciences’ Biktarvy, GSK’s Shingrix and Pfizer’s Ibrance have gone up to start the year, a database from 46brooklyn shows,” FiercePharma reports.

For the FiercePharma story, read: https://www.fiercepharma.com/pharma/pfizer-gsk-abbvie-and-many-more-ring-new-year-price-hikes-report

For the Reuters report, see: https://www.reuters.com/business/healthcare-pharmaceuticals/drugmakers-raise-prices-least-350-drugs-us-january-2022-12-30/